You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

avelumab

Showing 51 - 75 of 171
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Extranodal NK-T-Cell Trial in Seoul (avelumab)

Active, not recruiting
  • Lymphoma, Extranodal NK-T-Cell
  • avelumab
  • Seoul, Korea, Republic of
    81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Sep 22, 2021

Metastatic Colorectal Cancer Trial in Hamburg (Avelumab)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Avelumab
  • Hamburg, Germany
    Universitätsklinikum Hamburg-Eppendorf
Oct 14, 2021

Metastatic NSCLC (NSCLC) Trial in Sacramento (Avelumab, Stereotactic ablative radiotherapy (SAR))

Completed
  • Metastatic Non-small Cell Lung Cancer (NSCLC)
  • Avelumab
  • Stereotactic ablative radiotherapy (SAR)
  • Sacramento, California
    UC Davis
Oct 19, 2021

Colorectal Tumors, Colorectal Tumors, Colorectal Carcinoma Trial in Washington, Bethesda (Avelumab, Ad-CEA vaccine, Bevacizumab)

Terminated
Has Results
  • Colorectal Tumors
  • +4 more
  • Avelumab
  • +6 more
  • Washington, District of Columbia
  • +1 more
Dec 10, 2021

Merkel Cell Carcinoma Trial in United States (Avelumab, Comprehensive Ablative Radiation Therapy)

Recruiting
  • Merkel Cell Carcinoma
  • Avelumab
  • Comprehensive Ablative Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Jan 5, 2022

Metastatic sRCC Trial in Philadelphia (Avelumab, Gemcitabine)

Recruiting
  • Metastatic sRCC
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jul 22, 2021

Metastatic Renal Cell Carcinoma, Fumarate Hydratase Deficient Renal Cell Carcinoma, Succinate Dehydrogenase Deficient Renal Cell

Recruiting
  • Metastatic Renal Cell Carcinoma
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Dec 21, 2021

Breast Cancer Metastatic Trial in United States (Paclitaxel, Pelareorep, Avelumab)

Active, not recruiting
  • Breast Cancer Metastatic
  • Miami, Florida
  • +17 more
Sep 1, 2022

Locally Advanced or Metastatic Urothelial Carcinoma Trial in United States (Avelumab, Sacituzumab Govitecan, M6223)

Recruiting
  • Locally Advanced or Metastatic Urothelial Carcinoma
  • Avelumab
  • +3 more
  • Coeur d'Alene, Idaho
  • +19 more
Oct 4, 2022

NSCLC, Tumors Trial in Canada, Poland, Romania (Debio 1143, Avelumab)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Neoplasms
  • Debio 1143
  • Avelumab
  • Edmonton, Alberta, Canada
  • +8 more
May 30, 2022

Japanese RCC Patients Treated With Avelumab Plus Axitinib as

Completed
  • Renal Cell Carcinoma
  • Kurume, Fukuoka, Japan
  • +11 more
Feb 22, 2022

HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma Trial in France, Spain, United

Recruiting
  • HPV-Related Carcinoma
  • +4 more
  • TG4001
  • Avelumab
  • Jacksonville, Florida
  • +16 more
Feb 14, 2022

Breast Cancer Trial in Philadelphia (HCQ, Avelumab, Palbociclib)

Recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jul 26, 2021

Esophageal Tumor, Metastatic Esophageal Squamous Cell Carcinoma Trial in Taipei (Avelumab)

Enrolling by invitation
  • Esophageal Tumor
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Avelumab
  • Taipei, Taiwan
    National Taiwan University Hospital, Taiwan
Sep 6, 2021

Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)

Active, not recruiting
  • Refractory Cancer
  • +6 more
  • SNK01
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Research Center
Sep 25, 2022

Merkel Cell Carcinoma, Merkel Cell Carcinoma, Stage I, Merkel Cell Carcinoma, Stage II Trial in Australia (Avelumab, Placebo)

Recruiting
  • Merkel Cell Carcinoma
  • +5 more
  • Avelumab
  • Placebo
  • Port Macquarie, New South Wales, Australia
  • +17 more
Aug 30, 2022

Axitinib Dose Reduction and Interruption for Adverse Event

Completed
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer
Sep 15, 2022

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) Trial in Worldwide

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • Metastatic Castration Resistant Prostate Cancer (mCRPC)
  • avelumab
  • +3 more
  • Rochester, New York
  • +4 more
Sep 17, 2021

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Malignant Glioma Trial in Germany (IDH1R132H peptide vaccine, Avelumab)

Recruiting
  • Malignant Glioma
  • IDH1R132H peptide vaccine
  • Avelumab
  • Berlin, Germany
  • +9 more
Feb 1, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Lymph Nodes, Metastatic Prostate Carcinoma Trial in

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +3 more
  • Avelumab
  • +4 more
  • Los Angeles, California
  • +22 more
Feb 2, 2023

Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

Completed
  • Solid Tumor, Adult
  • Minneapolis, Minnesota
  • +2 more
Jan 27, 2023

Endometrial Cancer Trial in Italy (Carboplatin, Paclitaxel, Avelumab)

Active, not recruiting
  • Endometrial Cancer
  • Brindisi, Italy
  • +10 more
Jul 27, 2021

Pancreatic Cancer Trial in Belgium, Singapore, United States (Avelumab, Binimetinib, Talazoparib)

Terminated
Has Results
  • Pancreatic Cancer
  • Avelumab
  • +2 more
  • Fayetteville, Arkansas
  • +17 more
Dec 28, 2021

Carcinoma, Hepatocellular Trial in Seoul (Avelumab)

Completed
  • Carcinoma, Hepatocellular
  • Avelumab
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 15, 2021